Log in to save to my catalogue

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11027674

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

About this item

Full title

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1375-1387

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Tumor-associated antigens (TAAs) have been tested in various clinical trials in cancer treatment but the patterns of specific T cell response to personalized TAA immunization remains to be fully understood. We report antigen-specific T cell responses in patients immunized with dendritic cell vaccines pulsed with personalized TAA panels. Tumor sampl...

Alternative Titles

Full title

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11027674

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11027674

Other Identifiers

ISSN

0340-7004

E-ISSN

1432-0851

DOI

10.1007/s00262-020-02496-w

How to access this item